LABORATORY RESEARCH Genomic Analysis of Circulating Cell Free DNA Infers Breast Cancer Dormancy Scientists hypothesized that genomic analysis of circulating free DNA isolated from plasma may form the basis for a means of detecting and monitoring breast cancer. [Genome Res] Abstract Mutation of a Single Allele of the Cancer Susceptibility Gene BRCA1 Leads to Genomic Instability in Human Breast Epithelial Cells Here, researchers show that heterozygous BRCA1 inactivation results in genomic instability in nontumorigenic human breast epithelial cells in vitro and in vivo. [Proc Natl Acad Sci USA] Abstract Mitochondrial Targeting Liposomes Incorporating Daunorubicin and Quinacrine for Treatment of Relapsed Breast Cancer Arising from Cancer Stem Cells The objectives of this study were to construct a kind of mitochondrial targeting daunorubicin plus quinacrine liposomes for treating and for preventing the recurrence of breast cancer arising from the cancer stem cells. [Biomaterials] Abstract Cytoplasmic Estrogen Receptor in Breast Cancer Investigators sought to determine the presence and implications of non-nuclear estrogen receptors in clinical specimens. [Clin Cancer Res] Abstract Chronic Oral Exposure to Bisphenol A Results in a Non-Monotonic Dose Response in Mammary Carcinogenesis and Metastasis in MMTV-ErbB2 Mice This study investigated the role of chronic, oral exposure to bisphenol A during adulthood on mammary carcinogenesis by using a transgenic mouse model which spontaneously develops tumors through over-expression of wildtype erbB2 (MMTV-erbB2). [Environ Health Perspect] Abstract | Press Release αB-Crystallin, an Effecter of Unfolded Protein Response, Confers Anti-VEGF Resistance to Breast Cancer via Maintenance of Intracrine VEGF in Endothelial Cells Findings underscore the importance of defining a role for intracrine VEGF signaling in sustaining aberrant tumor angiogenesis and strongly implicate unfolded protein response/αB-crystallin as dichotomous parts of a crucial regulation pathway for maintaining intracrine VEGF signaling. [Mol Cancer Res] Abstract CLINICAL RESEARCH High False-Negative Rate of HER2 Quantitative Reverse Transcription Polymerase Chain Reaction of the Oncotype DX Test: An Independent Quality Assurance Study This quality assurance study was undertaken to define the concordance rate between immunohistochemistry/fluorescent in situ hybridization and Genomic Health reverse transcription polymerase chain reaction HER2 assay. [J Clin Oncol] Abstract RIBBON-2: A Randomized, Double-Blind, Placebo-Controlled, Phase III Trial Evaluating the Efficacy and Safety of Bevacizumab in Combination with Chemotherapy for Second-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer This phase III study compared the efficacy and safety of bevacizumab combined with standard chemotherapy regimens versus chemotherapy alone as second-line treatment of patients with human epidermal growth factor receptor 2–negative metastatic breast cancer. [J Clin Oncol] Abstract Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison with the Genomic Health Recurrence Score in Early Breast Cancer This study suggests that the amount of prognostic information contained in four widely performed immunohistochemical assays is similar to that in the Genomic Health recurrence score. [J Clin Oncol] Abstract |